Introduction/MDMA Therapy for PTSD | Neural Pharm
Introducing the Neural Pharm Podcast, featuring your hosts Colby Burns, PharmD, and Christopher Toney, PharmD. Episode 1 establishes the mission of the podcast, and covers the groundbreaking MAPP1 and MAPP2 trials that established MDMA as a breakthrough therapy for PTSD. We also cover key safety data including drug interactions, pharmacokinetics (or metabolism), and pharmacogenomics (or gene-drug interactions). Come join us! ***Correction Alert: The Ted talk referenced by Colby in the conclusion of the podcast was given by Dr. Ben Sessa, not Sassa (see the attached video in the reference section)**** References:
- Mitchell J, et al. MDMA Assisted Therapy for Severe PTSD: A randomized, double blind, placebo controlled phase 3 study. Nature. 10 May 2021 <https://www.nature.com/articles/s41591-021-01336-3>
- Mental Health By the Numbers. National Alliance on Mental Illness. 2023. <https://www.nami.org/mhstats>
- Sessa B, et al. A Review of 3,4-methylenedioxymethamphetamine (MDMA) Assisted Psychotherapy. 2019(10). <https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00138/full>
- Sessa B. Is MDMA psychiatry’s antibiotic? Tedx University of Bristol. 5 July 2016.
- Silverstone P. The Promise of Psychedelics: Science Based Hope for Better Mental Health. 2022 Apr 21. Ingenium books.
You May Also Like

Amy & T.J.
iHeartPodcasts

GÉOPOLITIQUE PROFONDE (www.geopolitique-profonde.com)
Franck Pengam

NTD News Today
NTD+

RDN Radio – Roma Daily News
Radio RDN - RomaDailyNews

Packernet Podcast: Daily Green Bay Packers Podcast
AC Sports

BSD Now
JT Pennington

Las noticias de la SER
SER Podcast

Gossip News
Gossip News
The Podcast of the Lotus Eaters
lotuseaters.com

SMWX
Sizwe Mpofu-Walsh
Community discussion